1
|
Miyano K, Okamoto S, Yamauchi A, Kawai C, Kajikawa M, Kiyohara T, Itsumi M, Taura M, Kuribayashi F. The downregulation of NADPH oxidase Nox4 during hypoxia in hemangioendothelioma cells: a possible role of p22 phox on Nox4 protein stability. Free Radic Res 2022; 55:996-1004. [PMID: 35012414 DOI: 10.1080/10715762.2021.2009116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
NADPH oxidase (Nox) 4 produces H2O2 by forming a heterodimer with p22phox and is involved in hemangioendothelioma development through monocyte chemoattractant protein-1 (MCP-1) upregulation. Here, we show that Nox4 protein levels were maintained by p22phox in hemangioendothelioma cells and Nox4 protein stability was dependent on p22phox coexpression. Conversely, the degradation of Nox4 monomer was enhanced by p22phox knockdown. Under hypoxic conditions in hemangioendothelioma cells, p22phox was downregulated at the mRNA and protein levels. Downregulation of p22phox protein resulted in the enhanced degradation of Nox4 protein in hypoxia-treated hemangioendothelioma cells. In contrast, Nox2, a Nox isoform, was not altered at the protein level under hypoxic conditions. Nox2 exhibited a higher affinity for p22phox compared with Nox4, suggesting that when coexpressed with Nox4 in the same cells, Nox2 acts as a competitor. Nox2 knockdown restored Nox4 protein levels partially reduced by hypoxic treatment. Thus, Nox4 protein levels were attenuated in hypoxia-treated cells resulting from p22phox depletion. MCP-1 secretion was decreased concurrently with hypoxia-induced Nox4 downregulation compared with that under normoxia.
Collapse
Affiliation(s)
- Kei Miyano
- Department of Biochemistry, Kawasaki Medical School, Okayama, Japan
| | | | - Akira Yamauchi
- Department of Biochemistry, Kawasaki Medical School, Okayama, Japan
| | - Chikage Kawai
- Department of Biochemistry, Kawasaki Medical School, Okayama, Japan
| | - Mizuho Kajikawa
- Laboratory of Microbiology, Showa Pharmaceutical University, Machida, Japan
| | - Takuya Kiyohara
- Department of Cerebrovascular Disease and Neurology, Hakujyuji Hospital, Fukuoka, Japan.,Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
| | - Momoe Itsumi
- Department of Oral Microbiology and Immunology, Showa University, Shinagawa, Japan
| | - Masahiko Taura
- Department of Otorhinolaryngology, Faculty of Medicine, Fukuoka University, Fukuoka City, Japan
| | | |
Collapse
|
2
|
Xie X, Percipalle P. Elevated transforming growth factor β signaling activation in β-actin-knockout mouse embryonic fibroblasts enhances myofibroblast features. J Cell Physiol 2018; 233:8884-8895. [PMID: 29851084 PMCID: PMC6220129 DOI: 10.1002/jcp.26808] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2018] [Accepted: 05/30/2018] [Indexed: 01/08/2023]
Abstract
Signaling by the transforming growth factor‐β (TGF‐β) is an essential pathway regulating a variety of cellular events. TGF‐β is produced as a latent protein complex and is required to be activated before activating the receptor. The mechanical force at the cell surface is believed to be a mechanism for latent TGF‐β activation. Using β‐actin null mouse embryonic fibroblasts as a model, in which actin cytoskeleton and cell‐surface biophysical features are dramatically altered, we reveal increased TGF‐β1 activation and the upregulation of TGF‐β target genes. In β‐actin null cells, we show evidence that the enhanced TGF‐β signaling relies on the active utilization of latent TGF‐β1 in the cell culture medium. TGF‐β signaling activation contributes to the elevated reactive oxygen species production, which is likely mediated by the upregulation of Nox4. The previously observed myofibroblast phenotype of β‐actin null cells is inhibited by TGF‐β signaling inhibition, while the expression of actin cytoskeleton genes and angiogenic phenotype are not affected. Together, our study shows a scenario that the alteration of the actin cytoskeleton and the consequent changes in cellular biophysical features lead to changes in cell signaling process such as TGF‐β activation, which in turn contributes to the enhanced myofibroblast phenotype.
Collapse
Affiliation(s)
- Xin Xie
- Biology Program, Science Division, New York University Abu Dhabi (NYUAD), Abu Dhabi, United Arab Emirates
| | - Piergiorgio Percipalle
- Biology Program, Science Division, New York University Abu Dhabi (NYUAD), Abu Dhabi, United Arab Emirates.,Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden
| |
Collapse
|
3
|
Wang L, Ma R, Guo Y, Sun J, Liu H, Zhu R, Liu C, Li J, Li L, Chen B, Sun L, Tang J, Zhao D, Mo F, Niu J, Jiang G, Fu M, Brömme D, Zhang D, Gao S. Corrigendum: Antioxidant Effect of Fructus Ligustri Lucidi Aqueous Extract in Ovariectomized Rats Is Mediated through Nox4-ROS-NF-κB Pathway. Front Pharmacol 2017; 8:590. [PMID: 28860995 PMCID: PMC5574906 DOI: 10.3389/fphar.2017.00590] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2017] [Accepted: 08/15/2017] [Indexed: 11/13/2022] Open
Abstract
[This corrects the article on p. 266 in vol. 8, PMID: 28588482.].
Collapse
Affiliation(s)
- Lili Wang
- Cell and Biochemistry Lab, Preclinical Medicine School, Beijing University of Chinese MedicineBeijing, China
| | - Rufeng Ma
- Cell and Biochemistry Lab, Preclinical Medicine School, Beijing University of Chinese MedicineBeijing, China
| | - Yubo Guo
- Cell and Biochemistry Lab, Preclinical Medicine School, Beijing University of Chinese MedicineBeijing, China
| | - Jing Sun
- Chinese Material Medica School, Beijing University of Chinese MedicineBeijing, China
| | - Haixia Liu
- Cell and Biochemistry Lab, Preclinical Medicine School, Beijing University of Chinese MedicineBeijing, China
| | - Ruyuan Zhu
- Cell and Biochemistry Lab, Preclinical Medicine School, Beijing University of Chinese MedicineBeijing, China
| | - Chenyue Liu
- Chinese Material Medica School, Beijing University of Chinese MedicineBeijing, China
| | - Jun Li
- Modern Research Center for TCM, Beijing University of Chinese MedicineBeijing, China
| | - Lin Li
- Cell and Biochemistry Lab, Preclinical Medicine School, Beijing University of Chinese MedicineBeijing, China
| | - Beibei Chen
- Cell and Biochemistry Lab, Preclinical Medicine School, Beijing University of Chinese MedicineBeijing, China
| | - Liping Sun
- Cell and Biochemistry Lab, Preclinical Medicine School, Beijing University of Chinese MedicineBeijing, China
| | - Jinfa Tang
- The First Affiliated Hospital of He'nan TCM UniversityZhengzhou, Henan, China
| | - Dandan Zhao
- Diabetes Research Center, Beijing University of Chinese MedicineBeijing, China
| | - Fangfang Mo
- Diabetes Research Center, Beijing University of Chinese MedicineBeijing, China
| | - Jianzhao Niu
- Cell and Biochemistry Lab, Preclinical Medicine School, Beijing University of Chinese MedicineBeijing, China
| | - Guangjian Jiang
- Diabetes Research Center, Beijing University of Chinese MedicineBeijing, China
| | - Min Fu
- The Research Institute of McGill University Health CenterMontreal, QC, Canada
| | - Dieter Brömme
- Oral Biological Medicinal Science, University of British ColumbiaVancouver, BC, Canada
| | - Dongwei Zhang
- Diabetes Research Center, Beijing University of Chinese MedicineBeijing, China
| | - Sihua Gao
- Diabetes Research Center, Beijing University of Chinese MedicineBeijing, China
| |
Collapse
|
4
|
Wang L, Ma R, Guo Y, Sun J, Liu H, Zhu R, Liu C, Li J, Li L, Chen B, Sun L, Tang J, Zhao D, Mo F, Niu J, Jiang G, Fu M, Brömme D, Zhang D, Gao S. Antioxidant Effect of Fructus Ligustri Lucidi Aqueous Extract in Ovariectomized Rats Is Mediated through Nox4-ROS-NF-κB Pathway. Front Pharmacol 2017; 8:266. [PMID: 28588482 PMCID: PMC5438993 DOI: 10.3389/fphar.2017.00266] [Citation(s) in RCA: 31] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2017] [Accepted: 04/28/2017] [Indexed: 01/05/2023] Open
Abstract
Purpose: This study is designed to explore whether Fructus ligustri lucidi (FLL) exhibits antioxidant effect in ovariectomized (OVX) rats, and to identify the signaling pathway involved in this process. Methods: OVX rats were treated with FLL aqueous extract (3.5 g/kg) for 12 weeks. Serum, uteri, and tibias were harvested from the rats and the levels of total antioxidant capacity (TAC), nitric oxide (NO), malondialdehyde (MDA), 8-hydroxy-desoxyguanosine (8-OHdG), and superoxide dismutase (SOD) were determined. Changes in the levels of NF-κB-p65, phosphorylation of NF-κB-p65 (NF-κB-pp65), NF-κB inhibitor alpha (IκBα), phosphorylation of IκBα (p-IκBα), and NADPH oxidase 4 (Nox4) in uteri and tibias were determined by western blot, immunofluorescent and immunohistochemical analysis, respectively. In addition, the expression of cytochrome C (Cyto-C) and B-cell lymphoma-2 (Bcl-2) were determined in the tibias of rats. Histopathological changes in the bones were evaluated by hematoxylin-eosin staining. Bone mineral density (BMD) was determined in rat femurs by dual X-ray absorptiometry. Results: Treatment of OVX rats with FLL aqueous extract improved redox homeostasis by increasing the levels of TAC and NO as well as decreasing the levels of MDA and 8-OHdG in serum, tibias, and uteri. Further, FLL extract also downregulated the expression of Nox4, NF-κB-p65, NF-κB-pp65, and p-IκBα in the uteri and tibias. Furthermore, administration of FLL–OVX rats increased Bcl-2 expression and prevented cytoplasmic release of mitochondrial Cyto-C in the tibias. In addition, FLL treatment also improved bone microstructure and increased cortical bone thickness as well as increased BMD values in the femurs of OVX rats. Conclusions: FLL treatment may suppress oxidative stress response in OVX rats via regulating the Nox4/ROS/NF-κB signaling pathway. These results suggest the potential of using FLL as a natural antioxidant agent in preventing the development of osteoporosis.
Collapse
Affiliation(s)
- Lili Wang
- Cell and Biochemistry Lab, Preclinical Medicine School, Beijing University of Chinese MedicineBeijing, China
| | - Rufeng Ma
- Cell and Biochemistry Lab, Preclinical Medicine School, Beijing University of Chinese MedicineBeijing, China
| | - Yubo Guo
- Cell and Biochemistry Lab, Preclinical Medicine School, Beijing University of Chinese MedicineBeijing, China
| | - Jing Sun
- Chinese Material Medica School, Beijing University of Chinese MedicineBeijing, China
| | - Haixia Liu
- Cell and Biochemistry Lab, Preclinical Medicine School, Beijing University of Chinese MedicineBeijing, China
| | - Ruyuan Zhu
- Cell and Biochemistry Lab, Preclinical Medicine School, Beijing University of Chinese MedicineBeijing, China
| | - Chenyue Liu
- Chinese Material Medica School, Beijing University of Chinese MedicineBeijing, China
| | - Jun Li
- Modern Research Center for TCM, Beijing University of Chinese MedicineBeijing, China
| | - Lin Li
- Cell and Biochemistry Lab, Preclinical Medicine School, Beijing University of Chinese MedicineBeijing, China
| | - Beibei Chen
- Cell and Biochemistry Lab, Preclinical Medicine School, Beijing University of Chinese MedicineBeijing, China
| | - Liping Sun
- Cell and Biochemistry Lab, Preclinical Medicine School, Beijing University of Chinese MedicineBeijing, China
| | - Jinfa Tang
- The First Affiliated Hospital of He'nan TCM University, ZhengzhouHenan, China
| | - Dandan Zhao
- Diabetes Research Center, Beijing University of Chinese MedicineBeijing, China
| | - Fangfang Mo
- Diabetes Research Center, Beijing University of Chinese MedicineBeijing, China
| | - Jianzhao Niu
- Cell and Biochemistry Lab, Preclinical Medicine School, Beijing University of Chinese MedicineBeijing, China
| | - Guangjian Jiang
- Diabetes Research Center, Beijing University of Chinese MedicineBeijing, China
| | - Min Fu
- The Research Institute of McGill University Health CenterMontreal, QC, Canada
| | - Dieter Brömme
- Oral Biological Medicinal Science, University of British ColumbiaVancouver, BC, Canada
| | - Dongwei Zhang
- Diabetes Research Center, Beijing University of Chinese MedicineBeijing, China
| | - Sihua Gao
- Diabetes Research Center, Beijing University of Chinese MedicineBeijing, China
| |
Collapse
|